Mauran, Rolly B.
HRN: 27-90-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/08/2025
10/14/2025
IV
2.25g
Q6
Cap-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes